What we do
We work with one of the most important forces in healthcare: the Patient Movement.
■ Two decades of experience
■ Independent research
■ Database of 40,000 patient groups worldwide
■ Working in 23 languages
■ Analyses based on geographic regions and therapy areas
■ Feedback from 2400+ patient groups in 2024; a record number
■ An extensive evidence base of patient-group views
■ Identifying strategic actions for individual companies
■ This year, PatientView received a record 2,500+ survey responses from patient groups across the world.
The views of patients and patient groups are becoming more central to every action that pharmaceutical companies take—from selecting which treatments address patients’ unmet needs, to co-creating user-friendly patient information.
Patients and patient groups accordingly need a platform to share their opinions on the pharmaceutical industry, and to offer up their ideas about how individual pharmaceutical companies can improve.
Featured report
What Companies Say
Alongside PatientView's 2023/24 annual survey, pharma provided their own perspectives on patient-group relationships — based on their own experiences, and with their own case studies — as part of this new report.
Latest Blogs
Patient groups at the heart of healthcare: a vital partnership for a healthier world
November 2024: Over the past 40 years, the role of patient groups has undergone a radical transformation. Historically, patients—and the groups representing them—had minimal influence on their healthcare systems, frequently… Continue reading “Patient groups at the heart of healthcare: a vital partnership for a healthier world”
PatientView’s Corporate Reputation of Pharma 2023/24: Insights from Specialised Cancer Patient Groups
July 2024: The field of oncology, cancer research and cancer treatment has seen continued investment over the last few years. In the UK, cancer incidence rates are projected to rise… Continue reading “PatientView’s Corporate Reputation of Pharma 2023/24: Insights from Specialised Cancer Patient Groups”